Antigenics looks to foreign regulators before U.S. By: MarketWatch July 01, 2009 at 18:57 PM EDT Scrappy biotech firm's stock has soared on hopes that it will finally be able to win regulatory approval for a kidney-cancer vaccine. Read More >> Related Stocks: Gsk Plc ADR